Check out our piece on anticoagulation and antiplatelet agent use among patients with VWD and cardiac disease featured in Blood Advances!

Huge thanks to Nathan Connell, MD, MPH and Brigham and Women’s Hematology for the help answering this critical question!

ashpublications.org/bloodadvances/…

Don't miss the final episode of the 2023-24 National Thrombosis Seminar series on May 28th!

Explore ' #Anticoagulation and #Platelet Inhibition Prescribing in 2024 with speakers Geoff Barnes, MD, MSc, and Jordan Schaefer, MD.

Register to attend: buff.ly/3UKokYf

WEBINAR: Join us tonight at 8pm ET for 'Evaluating All Aspects of PE Treatment: Patient Selection, Technology, and Treatment Algorithms'.

Register: csavevents.zoom.us/webinar/regist…

Sponsored by The PERT Consortium™️ & The Society of Vascular Medicine, and supported by Penumbra, Inc.

Blood clot survivors: Take anonymous survey on your experience with heavy menstrual bleeding while taking anticoagulants. You can help the health care community better recognize & treat heavy menstrual bleeding due to blood thinners. stoptheclot.org/news/survey-he…

#stoptheclot #dvt #pe

A trip to Nashville wouldn’t be complete unless you found your way on stage to sing “My Brown Eyed Girl”, right? Thanks to allison burnett for joining me! Cheers to the incredible LynnMarie and E3 Americana band

Important basics of Warfarin for our Anticoagulation Forum Boot Camp attendees: building the foundation for #anticoagulationstewarship

After discontinuing anticoagulation for unprovoked VTE, there were many more VTE recurrences than major bleeds

But mortality due to recurrence or bleeding was similar

Here: pubmed.ncbi.nlm.nih.gov/38762019/

Thanks RPTH and Bethany Samuelson MD, MCR our work even more relevant today. Coordinating w multiple providers, services, interventions to keep patients on all anticoagulants safe
Brigham and Women’s (BWH) Pharmacy Department Brigham and Women’s Hematology

Really important analysis from the ARTESiA trial to help physicians to find patients with subclinical AF who might benefit the most from OAC. Results just presented at the LBCT session at HRS. William F McIntyre Jeff Healey PHRI.ca Population Health Research Institute 🇨🇦 Duke Clinical Research Institute

#ICYMI : ACC/AHA/Multisociety PAD Guideline was released last week!

This Guideline-at-a-Glance highlights practice-changing recommendations from the guideline to accelerate adoption into clinical practice: bit.ly/3JZvxi7

The best hour of bootcamp: answering your burning questions! #anticoagulationstewards

We work hard, and we play hard! Thanks for a great Spring 2024 Boot Camp Anticoagulation Forum staff, faculty, and our wonderful attendees! allison burnett BishoyRagheb_PharmD Geoff Barnes Anita Raj and Nate Clark! 🩸 #anticoagulationstewardship

Day 2 of Boot Camp 2024 is off and running! allison burnett presenting on VTE primary prophylaxis.

1/ Right, ANNEXA-I has dropped. The 1st ever RCT of a reversal agent for DOACs. Randomised patients with intracranial hemorrhage to andexanet alfa or usual care. Stopped early as it met its primary endpoint.
There are A LOT of talking points - LET'S GO! nejm.org/doi/full/10.10…

From veins to brains: Shifting paradigm in Cancer Associated Thrombosis.

Strokes are common just before or right after cancer diagnosis. Cancer types, prior history of stroke and tumor stage are important predictors of CVA. More studies are needed. #ICTHIC2024

Andexanet et Hgie Cérébrale medvasc.info/archives-blog/… Paul Édouard Ternier Manas Elodie Filière FAVA-Multi Miikka. Vikkula Jacques Saffar Jean-François RENUCCI Gabrielle Sarlon B Soudet Simon Marie Sevestre Laurence Boon PHARMAGEEK #hcsmeufr JLE - John Libbey Eurotext Richard Scott sfnv Medscape Neurology Femmes et AVC - Women and Stroke Anticoagulation Forum

Day 1 Chalk Talk featuring our expert faculty!

Self proclaimed 'warfarin king' Nate Clark and Bishoy Ragheb discuss optimizing warfarin dosing w/presenter Andrea van Beek using old fashioned adding machines! 👏🏼